Faculty profile

Nicole Ezer

ResearcherRespirologyMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Nicole Ezer

Researcher

Respirology

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
21 publications in the last five years, latest in 2026.
Senior (last) author on 4 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

250

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cardiovascular Disease Chronic Obstructive Pulmonary Disease Lung Cancer Screening

Latest papers

Risk-based lung cancer screening with low-dose computed tomography in a Canadian province: Evaluation results of a demonstration project in Quebec, Canada.
Journal of medical screening · 2026
Blood eosinophil counts and postoperative outcomes in early-stage lung cancer: a retrospective cohort study.
Respiratory research · 2026 · senior author
KRAS ctDNA Detection in Patients With Resectable Lung Adenocarcinoma.
Clinical lung cancer · 2025

All 34 publications

Latest funding

An international platform for finding the optimal therapies for Pneumocystis jirovecii pneumonia: The PCP Platform
CIHR · 2024 · Co-investigator
$1,683,000
Improving Canadian Lung Cancer Screening Efficiency with a Computed Tomography Risk Classifier
CIHR · 2022 · Co-investigator
$914,175
Harnessing predictive analytics for personalized high-value health: nesting clinical decision support for cardiovascular disease and chronic obstructive pulmonary disease in a provincial lung cancer screening program
CIHR · 2021 · Nominated PI
$466,650

All 3 grants and awards

34 publications.

Risk-based lung cancer screening with low-dose computed tomography in a Canadian province: Evaluation results of a demonstration project in Quebec, Canada.

Massougbodji J, Rodrigue S, Martel S, Lizotte H, Théberge I, Boily G, Ezer N, Bouchard N, Guertin MH

Journal of medical screening2026

DOI: 10.1177/09691413261481721 PMID: 42754844

Blood eosinophil counts and postoperative outcomes in early-stage lung cancer: a retrospective cohort study.

Mugutso E, Freund O, Pitrou I, Ghatak A, Roux C, Jacobson S, Stetco JR, Kutzkel S, Bar-Shai A, Smith B, Ezer N

Respiratory research2026Senior author

DOI: 10.1186/s12931-026-03672-9 PMID: 42067843

KRAS ctDNA Detection in Patients With Resectable Lung Adenocarcinoma.

De Meo ML, Seitlinger J, Rayes RF, Walsh LC, Shahzad MH, Tsering T, Saleh R, Ezer N, Shieh B, Wong A, Owen S, Walsh L, Fiset PO, Burnier JV, Spicer JD

Clinical lung cancer2025

DOI: 10.1016/j.cllc.2025.05.006 PMID: 40634198

Lung Cancer Screening in Family Members and Peers of Patients With Lung Cancer: Protocol for a Prospective Cohort Study.

Pitrou I, Petrangelo A, Besson C, Pepe C, Waschke AH, Agulnik J, Gonzalez AV, Ezer N

JMIR research protocols2025Senior author

DOI: 10.2196/58529 PMID: 40153794

Patient Factors and Clinical Efficacy of Early Identification and Treatment of Chronic Obstructive Pulmonary Disease and Asthma

Tardif A, Whitmore GA, Vandemheen KL, Bergeron C, Boulet L-P, Cote A, McIvor RA, Penz E, Field SK, Lemière C

American Journal of Respiratory and Critical Care Medicine20254 citations

DOI: 10.1164/rccm.202505-1260oc

Cough in Adults with Undiagnosed Respiratory Symptoms.

Shin S, Poliwoda J, Whitmore GA, Vandemheen KL, Bergeron C, Boulet L-P, Côté A, Field SK, Penz E, McIvor RA

Annals of the American Thoracic Society20253 citations

DOI: 10.1513/annalsats.202412-1329oc

Association between lung function and sleep disorder symptoms in a community‐based multi‐site case‐finding study

Mazzola R, Aaron SD, Vandemheen KL, Mulpuru S, Bergeron C, Lemière C, Côté A, Boulet L, Field SK, Penz E

Journal of Sleep Research2025

DOI: 10.1111/jsr.14356

Development of a clinical risk score for the prediction of Pneumocystis jirovecii pneumonia in hospitalised patients.

Mappin-Kasirer B, Del Corpo O, Gingras MA, Hass A, Hsu JM, Costiniuk CT, Ezer N, Fraser RS, Lee TC, McDonald EG

BMC infectious diseases2024

DOI: 10.1186/s12879-024-09957-y PMID: 39333914

Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network.

Pilon Y, Rokah M, Seitlinger J, Sepesi B, Rayes RF, Cools-Lartigue J, Najmeh S, Sirois C, Mulder D, Ferri L, Abdulkarim B, Ezer N, Fraser R, Camilleri-Broët S, Fiset PO, Wong A, Sud S, Langleben A, Agulnik J, Pepe C, Shieh B, Hirsh V, Ofiara L, Owen S, Spicer JD

Clinical lung cancer2024

DOI: 10.1016/j.cllc.2023.12.005 PMID: 38378398

A Statistical Testing Strategy Accounting for Random and Nonrandom (Skewed) X-Chromosome Inactivation Identifies Lung Cancer Susceptibility Loci among Smokers.

Jantzen R, Camilleri-Broët S, Ezer N, Broët P

Human heredity2024

DOI: 10.1159/000539520 PMID: 38880085

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2021

Subject: Prospective PhD student: Cardiovascular Disease Dear Professor Ezer, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Risk-based lung cancer screening with low-dose computed tomography in a Canadian province: Evaluation results of a demonstration project in Quebec, Canada." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Harnessing predictive analytics for personalized high-value health: nesting clinical decision support for cardiovascular disease and chronic obstructive pulmonary disease in a provincial lung cancer screening program" (2021), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Nicole Ezer

Research

Latest papers

Latest funding

Risk-based lung cancer screening with low-dose computed tomography in a Canadian province: Evaluation results of a demonstration project in Quebec, Canada.

Blood eosinophil counts and postoperative outcomes in early-stage lung cancer: a retrospective cohort study.

KRAS ctDNA Detection in Patients With Resectable Lung Adenocarcinoma.

Lung Cancer Screening in Family Members and Peers of Patients With Lung Cancer: Protocol for a Prospective Cohort Study.

Patient Factors and Clinical Efficacy of Early Identification and Treatment of Chronic Obstructive Pulmonary Disease and Asthma

Cough in Adults with Undiagnosed Respiratory Symptoms.

Association between lung function and sleep disorder symptoms in a community‐based multi‐site case‐finding study

Development of a clinical risk score for the prediction of Pneumocystis jirovecii pneumonia in hospitalised patients.

Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network.

A Statistical Testing Strategy Accounting for Random and Nonrandom (Skewed) X-Chromosome Inactivation Identifies Lung Cancer Susceptibility Loci among Smokers.

An international platform for finding the optimal therapies for Pneumocystis jirovecii pneumonia: The PCP Platform

Improving Canadian Lung Cancer Screening Efficiency with a Computed Tomography Risk Classifier

Harnessing predictive analytics for personalized high-value health: nesting clinical decision support for cardiovascular disease and chronic obstructive pulmonary disease in a provincial lung cancer screening program

Frequent collaborators

Sunita Mulpuru

Andrew McIvor

Erika Penz

Samir Gupta

Andrea Benedetti

Andrea Benedetti

Pierre-Olivier Fiset

Tetyana Kendzerska

Kevin Schwartzman

Nick Daneman

Ranjani Somayaji

Ramy Saleh

Jonathan Spicer

Samir Gupta

Sylvain Lother

Derek MacFadden

Guillaume Butler-Laporte

Emilie Trinh

Cecilia Costiniuk

Céline Bergeron

Michaeline McGuinty

Miranda So

Bryan Coburn

Gregory Moullec

Cecilia Costiniuk

Dennis Jensen

Salman Qureshi

Benjamin Smith

Logan Walsh

Derek MacFadden

Erika Penz

Jean Bourbeau

Lehana Thabane